This inventor holds 2 USPTO granted patents. Top assignee: Chemagis Ltd.. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: Deby Yigal: Innovator in Pharmaceutical Chemistry
Introduction
Deby Yigal is a notable inventor based in Tzur Yigal, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for preparing important compounds.
Latest Patents
Deby Yigal holds 2 patents that showcase his innovative work. His latest patents include a process for the preparation of midodrine, which involves the hydrogenolysis of substituted 2-dibenzylamino-N-[2-(2',5'-dimethoxyphenyl)-2-hydroxy-ethyl]acetamide. This invention provides a method for synthesizing 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide, a compound with potential therapeutic applications.
Career Highlights
Deby Yigal is currently employed at Chemagis Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding and production of pharmaceutical intermediates.
Collaborations
Throughout his career, Deby has collaborated with talented individuals such as Michael Brand and Ronit Chen. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Deby Yigal's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of important pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile